PRKCB NanoBRET Target Engagement Intracellular Kinase Assay for screening of compounds binding to the target.
PRKCB (beta)
PRKCB
PRKCB1, PKCB, PRKCB2, MGC41878, PKC-beta, PKC-beta1
HEK293 human epithelial cell line from ATCC
384-well plate format using Promega’s NanoBRET TE Intracellular Kinase Assay
HEK293 cells transiently expressing NanoLuc-PRKCB Fusion Vector were seeded into the wells of 384-well plates. The transfected cells were stimulated with PMA, pre-treated with NanoBRET Tracer K-10, and then treated with reference compound Staurosporine for 1 hour. The BRET signal was measured on an Envision 2104 Multilabel Reader. IC50 value was calculated and IC50 curve was plotted using the GraphPad Prism program based on a sigmoidal dose response equation.
Binding of compound to target
| Compounds | IC50 (M) |
|---|---|
| Staurosporine | 2.803e-009 |
Malvern, PA, USA
More information can be found on our website NanoBRET Target Engagement Intracellular Kinase Assay Services
Reference compound IC50 for PRKCB
